From the publishers of JADPRO

HR+ HER2- Breast Cancer Resource Center

Advertisement

Advances in Trop-2 targeted antibody-drug conjugates for breast cancer: Mechanisms, clinical applications, and future directions

Last Updated: Monday, December 9, 2024

A recent review looks at advancements in Trop-2-targeted antibody-drug conjugates. It focuses on new research directions as well as potential strategies to improve treatment outcomes and patient quality of life.

Frontiers in Immunology
Advertisement
News & Literature Highlights
Advertisement
Advertisement